Arima Genomics, Inc., announced the broad commercial launch of the Aventa Lymphoma test at the Society of Hematologic Oncology (SOHO 2025) meeting in Houston, Texas. Offered through the CLIA-certified ...

CARLSBAD, Calif., October 15, 2025--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection ...

The Mayo Clinic announced that it has developed a new test to help with diagnosis and treatment for patients with diffuse large B-cell lymphoma. Diffuse large B-cell lymphoma is the most common type ...

March 11, 2010 — A new research finding has the potential to revolutionize the treatment of Hodgkin's lymphoma, says an expert in the field. This finding appears to be the breakthrough we have been ...

The primary way to diagnose lymphoma involves a lymph node biopsy. However, doctors may utilize several other diagnostic procedures depending on a person’s lymphoma. Doctors can use blood tests, ...

Circulating tumor DNA found in blood plasma may help predict if the likelihood of relapse for patients with large B-cell lymphoma, according to recent research. With next-generation sequencing, ...

A new test may help people with a common form of non-Hodgkin’s lymphoma know how aggressive their cancer is. Follicular lymphoma is the second most common form of non-Hodgkin’s lymphoma and accounts ...

Rochester, Minn.-based Mayo Clinic has developed the Lymph2Cx test, the first lymphoma genomic diagnostic test in the United States. The Lymph2Cx test, which is the first test to go into practice from ...

CARLSBAD, Calif., September 03, 2025--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection ...